263 related articles for article (PubMed ID: 9395240)
1. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
[TBL] [Abstract][Full Text] [Related]
2. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression.
Faris M; Kokot N; Latinis K; Kasibhatla S; Green DR; Koretzky GA; Nel A
J Immunol; 1998 Jan; 160(1):134-44. PubMed ID: 9551965
[TBL] [Abstract][Full Text] [Related]
3. MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage.
Bild AH; Mendoza FJ; Gibson EM; Huang M; Villanueva J; Garrington TP; Jove R; Johnson GL; Gibson SB
Oncogene; 2002 Sep; 21(43):6649-56. PubMed ID: 12242663
[TBL] [Abstract][Full Text] [Related]
4. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
[TBL] [Abstract][Full Text] [Related]
5. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42.
Fanger GR; Johnson NL; Johnson GL
EMBO J; 1997 Aug; 16(16):4961-72. PubMed ID: 9305638
[TBL] [Abstract][Full Text] [Related]
6. MEKK1 induces c-Jun complexes that act as negative regulators for cell survival and proliferation of HCC cells.
Komoda F; Shino Y; Hirano T; Okutomi Y; Okamoto H; Hayashi Y; Suyama T; Ebara M; Saisho H; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):553-9. PubMed ID: 12168099
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
[TBL] [Abstract][Full Text] [Related]
8. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption.
Yujiri T; Sather S; Fanger GR; Johnson GL
Science; 1998 Dec; 282(5395):1911-4. PubMed ID: 9836645
[TBL] [Abstract][Full Text] [Related]
9. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
Boldt S; Weidle UH; Kolch W
Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
[TBL] [Abstract][Full Text] [Related]
10. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis.
Widmann C; Gerwins P; Johnson NL; Jarpe MB; Johnson GL
Mol Cell Biol; 1998 Apr; 18(4):2416-29. PubMed ID: 9528810
[TBL] [Abstract][Full Text] [Related]
11. MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions.
Christerson LB; Vanderbilt CA; Cobb MH
Cell Motil Cytoskeleton; 1999; 43(3):186-98. PubMed ID: 10401575
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner.
Mandic A; Viktorsson K; Molin M; Akusjärvi G; Eguchi H; Hayashi SI; Toi M; Hansson J; Linder S; Shoshan MC
Mol Cell Biol; 2001 Jun; 21(11):3684-91. PubMed ID: 11340162
[TBL] [Abstract][Full Text] [Related]
13. Two distinct steps of Bak regulation during apoptotic stress signaling: different roles of MEKK1 and JNK1.
Ihrlund LS; Hernlund E; Viktorsson K; Panaretakis T; Barna G; Sabapathy K; Linder S; Shoshan MC
Exp Cell Res; 2006 May; 312(9):1581-9. PubMed ID: 16529740
[TBL] [Abstract][Full Text] [Related]
14. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress.
Benhar M; Dalyot I; Engelberg D; Levitzki A
Mol Cell Biol; 2001 Oct; 21(20):6913-26. PubMed ID: 11564875
[TBL] [Abstract][Full Text] [Related]
15. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
Hartkamp J; Troppmair J; Rapp UR
Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
[TBL] [Abstract][Full Text] [Related]
16. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1.
Yan M; Dai T; Deak JC; Kyriakis JM; Zon LI; Woodgett JR; Templeton DJ
Nature; 1994 Dec 22-29; 372(6508):798-800. PubMed ID: 7997270
[TBL] [Abstract][Full Text] [Related]
17. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells.
Shiah SG; Chuang SE; Kuo ML
Mol Pharmacol; 2001 Feb; 59(2):254-62. PubMed ID: 11160861
[TBL] [Abstract][Full Text] [Related]
19. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.
Sadoshima J; Montagne O; Wang Q; Yang G; Warden J; Liu J; Takagi G; Karoor V; Hong C; Johnson GL; Vatner DE; Vatner SF
J Clin Invest; 2002 Jul; 110(2):271-9. PubMed ID: 12122119
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of MEKK1/2 signaling by serine-threonine kinase 38 (STK38).
Enomoto A; Kido N; Ito M; Morita A; Matsumoto Y; Takamatsu N; Hosoi Y; Miyagawa K
Oncogene; 2008 Mar; 27(13):1930-8. PubMed ID: 17906693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
